Literature DB >> 24514261

Bone: Which model to predict fracture risk?

Roger Bouillon1, Dirk Vanderschueren1.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 24514261     DOI： 10.1038/nrendo.2014.15

Source DB:  PubMed          Journal:  Nat Rev Endocrinol        ISSN： 1759-5029            Impact factor:   43.330


× No keyword cloud information.
  10 in total

1.  Evaluation of the FRAX and Garvan fracture risk calculators in older women.

Authors:  Mark J Bolland; Amanda Ty Siu; Barbara H Mason; Anne M Horne; Ruth W Ames; Andrew B Grey; Greg D Gamble; Ian R Reid
Journal:  J Bone Miner Res       Date:  2011-02       Impact factor: 6.741

2.  Evaluating the yield of medical tests.

Authors:  F E Harrell; R M Califf; D B Pryor; K L Lee; R A Rosati
Journal:  JAMA       Date:  1982-05-14       Impact factor: 56.272

3.  FRAX provides robust fracture prediction regardless of socioeconomic status.

Authors:  S L Brennan; W D Leslie; L M Lix; H Johansson; A Oden; E McCloskey; J A Kanis
Journal:  Osteoporos Int       Date:  2013-11-05       Impact factor: 4.507

4.  New horizons in fracture risk assessment.

Authors:  Terry J Aspray
Journal:  Age Ageing       Date:  2013-07-26       Impact factor: 10.668

Review 5.  Performance of risk assessment instruments for predicting osteoporotic fracture risk: a systematic review.

Authors:  S Nayak; D L Edwards; A A Saleh; S L Greenspan
Journal:  Osteoporos Int       Date:  2013-10-09       Impact factor: 4.507

6.  Development of prognostic nomograms for individualizing 5-year and 10-year fracture risks.

Authors:  N D Nguyen; S A Frost; J R Center; J A Eisman; T V Nguyen
Journal:  Osteoporos Int       Date:  2008-03-07       Impact factor: 4.507

Review 7.  The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women.

Authors:  J A Kanis; A Oden; O Johnell; H Johansson; C De Laet; J Brown; P Burckhardt; C Cooper; C Christiansen; S Cummings; J A Eisman; S Fujiwara; C Glüer; D Goltzman; D Hans; M-A Krieg; A La Croix; E McCloskey; D Mellstrom; L J Melton; H Pols; J Reeve; K Sanders; A-M Schott; A Silman; D Torgerson; T van Staa; N B Watts; N Yoshimura
Journal:  Osteoporos Int       Date:  2007-02-24       Impact factor: 4.507

8.  Risk factors for treatment failure with antiosteoporosis medication: the global longitudinal study of osteoporosis in women (GLOW).

Authors:  Adolfo Díez-Pérez; Jonathan D Adachi; Silvano Adami; Frederick A Anderson; Steven Boonen; Roland Chapurlat; Juliet E Compston; Cyrus Cooper; Stephen H Gehlbach; Susan L Greenspan; Frederick H Hooven; Andrea Z LaCroix; Jeri W Nieves; J Coen Netelenbos; Johannes Pfeilschifter; Maurizio Rossini; Christian Roux; Kenneth G Saag; Stuart Silverman; Ethel S Siris; Allison Wyman; Sophie K Rushton-Smith; Nelson B Watts
Journal:  J Bone Miner Res       Date:  2014-01       Impact factor: 6.741

9.  Empirically based composite fracture prediction model from the Global Longitudinal Study of Osteoporosis in Postmenopausal Women (GLOW).

Authors:  Gordon FitzGerald; Juliet E Compston; Roland D Chapurlat; Johannes Pfeilschifter; Cyrus Cooper; David W Hosmer; Jonathan D Adachi; Frederick A Anderson; Adolfo Díez-Pérez; Susan L Greenspan; J Coen Netelenbos; Jeri W Nieves; Maurizio Rossini; Nelson B Watts; Frederick H Hooven; Andrea Z LaCroix; Lyn March; Christian Roux; Kenneth G Saag; Ethel S Siris; Stuart Silverman; Stephen H Gehlbach
Journal:  J Clin Endocrinol Metab       Date:  2014-01-01       Impact factor: 5.958

10.  The Global Longitudinal Study of Osteoporosis in Women (GLOW): rationale and study design.

Authors:  F H Hooven; J D Adachi; S Adami; S Boonen; J Compston; C Cooper; P Delmas; A Diez-Perez; S Gehlbach; S L Greenspan; A LaCroix; R Lindsay; J C Netelenbos; J Pfeilschifter; C Roux; K G Saag; P Sambrook; S Silverman; E Siris; N B Watts; F A Anderson
Journal:  Osteoporos Int       Date:  2009-05-26       Impact factor: 4.507
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.